Skip to Content Skip to Content
Variant-targeted COVID-19 boosters test the promise of mRNA technology
The Wall Street Journal

Variant-targeted COVID-19 boosters test the promise of mRNA technology

Drew Weissman of the Perelman School of Medicine, whose key discoveries about mRNA contributed to Moderna and BioNTech, says that mRNA is designed to rapidly adapt to new strains and variants of virus.

Aug 21, 2022

Personalized immunotherapy shows promise beyond cancer
ScienceFriday.com

Personalized immunotherapy shows promise beyond cancer

Carl June of the Perelman School of Medicine is interviewed on the use of customized immunotherapy to treat new blood cancers, as well as its potential for treating solid state cancers and autoimmune diseases.

Aug 12, 2022

Do chemicals in sunscreens threaten aquatic life? A new report says a thorough assessment is ‘urgently needed,’ while also calling sunscreens essential protection against skin cancer
The Conversation

Do chemicals in sunscreens threaten aquatic life? A new report says a thorough assessment is ‘urgently needed,’ while also calling sunscreens essential protection against skin cancer

A report co-authored by PIK Professor Karen Glanz weighs the negative environmental effects of UV filters against their positive impact on human health.

Aug 9, 2022

University of Pennsylvania’s first NFT commemorates mRNA research
Lots of gold blobs, some larger and closer to the front of the image, some smaller and farther away, on a pinkish background.

A still image from the 3D animated video component of the non-fungible token, which will also include patent documents and a letter from Drew Weissman of Penn Medicine. (Image: Courtesy Penn Medicine and Christie’s)

University of Pennsylvania’s first NFT commemorates mRNA research

Proceeds from the July auction of the non-fungible token—a digital asset—will benefit ongoing research at Penn.

Penn Medicine , Brandon Lausch , Peter Winicov

Subscribe to Innovation: Increase Knowledge